Picture of Viveve Medical logo

VIVE — Viveve Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Viveve Medical Inc reports results for the quarter ended in March - Earnings Summary

* Viveve Medical Inc  VIVE.OQ  reported a quarterly adjusted
loss
of 67 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 67
cents per share.
    * Revenue rose 13.2% to $1.64 million from a year ago; 
analysts
expected $1.74 million. 
    * Viveve Medical Inc's reported EPS for the quarter was a
loss
of 67 cents​.
    * The mean earnings estimate of analysts had fallen by
about 20.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Viveve Medical Inc shares had fallen by 29.2% this
quarter and
lost 34.2% so far this year.
    * The company reported a quarterly loss of $7.15 million.
    * Wall Street's median 12-month price target for Viveve
Medical
Inc is $6.88 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Viveve Medical

See all news